[ad_1]
A Baltimore plant run by Emergent BioSolutions that produces coronavirus vaccines has ruined a batch of Johnson & Johnson vaccines, according to a statement released Wednesday by Johnson & Johnson.
Why is this important: The plant, which was scheduled to produce and ship tens of millions of doses of Johnson & Johnson next month, must now stop producing the single-dose vaccine while the Food and Drug Administration investigates the error, the New reported. York Times for the first time. Axios has confirmed that the report is correct.
The context: Workers at the plant, which produced the Johnson & Johnson and AstraZeneca vaccines, confused the ingredients between the two different types of vaccines, destroying 15 million doses of the Johnson & Johnson vaccine, according to the Times.
- The error is not expected to affect the doses of Johnson & Johnson currently supplied and administered nationally, as they were produced in the Netherlands.
- The Emergent BioSolutions plant had not yet been cleared by the FDA to manufacture a drug substance for Johnson & Johnson’s vaccine, but an application for clearance was pending, according to Politico.
What they say: Johnson & Johnson said on Wednesday that its “quality control process identified a batch of drug substance that did not meet quality standards at Emergent BioSolutions, a site not yet licensed to manufacture a drug substance for our COVID-19 vaccine.” .
- “This batch has never been advanced to the filling and finishing stages of our manufacturing process,” the company added.
- Johnson & Johnson said it would send manufacturing and quality control experts to the factory to oversee future production.
Thought bubble, via Caitlin Owens of Axios: The Times says the crash won’t stop the United States from meeting President Biden’s goal of having enough vaccines by the end of May for every adult, but in the global race against the virus, every dose counts.
[ad_2]
Source link